Stage IIIB Breast Cancer Terminated Phase 2 Trials for Tanespimycin (DB05134)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00096109Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast CancerTreatment